Effects of SGLT-2 inhibitors on renin-angiotensin-aldosterone system and their correlation with glucose metabolism in type 2 diabetes mellitus patients with hypertension: A prospective study. This evidence concerns the gene SLC5A2 and type 2 diabetes mellitus.